Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Pacira BioSciences
PCRX
$1.06B
| $1.33M | ﹤0.01% |
22,905
-19,088
| -45% | -$1.25M |
|
|
POLY
2077
DELISTED
Plantronics, Inc.
POLY
| $1.33M | ﹤0.01% |
33,649
-16,316
| -33% | -$648K |
|
|
FINM
2078
DELISTED
Marlin Technology Corporation Class A Ordinary Share
FINM
| $1.33M | ﹤0.01% |
135,016
+12,404
| +10% | +$122K |
|
2079
Rambus
RMBS
$10B
| $1.33M | ﹤0.01% |
61,989
-35,775
| -37% | -$885K |
|
|
RWT
2080
Redwood Trust
RWT
$580M
| $1.33M | ﹤0.01% |
172,764
-179,734
| -51% | -$1.65M |
|
|
HT
2081
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $1.33M | ﹤0.01% |
135,590
+13,707
| +11% | +$137K |
|
|
IAA
2082
DELISTED
IAA, Inc. Common Stock
IAA
| $1.33M | ﹤0.01% |
40,496
+22,620
| +127% | +$828K |
|
|
GRVY
2083
GRAVITY
GRVY
$429M
| $1.33M | ﹤0.01% |
26,044
+6,037
| +30% | +$316K |
|
|
KAIR
2084
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
| $1.33M | ﹤0.01% |
134,843
-21,649
| -14% | -$213K |
|
2085
Sunstone Hotel Investors
SHO
$2.18B
| $1.32M | ﹤0.01% |
133,148
+1,082
| +0.8% | +$12.4K |
|
|
CIO
2086
DELISTED
City Office REIT
CIO
| $1.32M | ﹤0.01% |
101,874
+20,702
| +26% | +$293K |
|
2087
AdvanSix
ASIX
$542M
| $1.32M | ﹤0.01% |
39,391
+375
| +1% | +$16.7K |
|
2088
BancFirst
BANF
$3.83B
| $1.32M | ﹤0.01% |
13,766
-21,937
| -61% | -$1.91M |
|
2089
CRISPR Therapeutics
CRSP
$4.88B
| $1.32M | ﹤0.01% |
21,649
+4,025
| +23% | +$237K |
|
2090
Kontoor Brands
KTB
$4.68B
| $1.32M | ﹤0.01% |
39,470
-9,595
| -20% | -$373K |
|
2091
Shake Shack
SHAK
$2.61B
| $1.31M | ﹤0.01% |
33,289
-22,575
| -40% | -$1.15M |
|
2092
Alarm.com
ALRM
$2.75B
| $1.31M | ﹤0.01% |
21,221
-18,653
| -47% | -$1.15M |
|
2093
Terex
TEX
$7.36B
| $1.31M | ﹤0.01% |
47,907
+6,021
| +14% | +$200K |
|
2094
Herbalife
HLF
$1.32B
| $1.31M | ﹤0.01% |
64,085
+42,806
| +201% | +$1.06M |
|
2095
Kulicke & Soffa
KLIC
$4.72B
| $1.31M | ﹤0.01% |
30,654
-27,752
| -48% | -$1.37M |
|
2096
Bloomin' Brands
BLMN
$774M
| $1.31M | ﹤0.01% |
78,674
-290,704
| -79% | -$5.9M |
|
2097
Pixelworks
PXLW
$39.3M
| $1.31M | ﹤0.01% |
57,083
| – | – |
|
2098
Sanmina
SANM
$10.4B
| $1.31M | ﹤0.01% |
32,065
-26,702
| -45% | -$1.1M |
|
2099
Valley National Bancorp
VLY
$8.02B
| $1.31M | ﹤0.01% |
125,440
-412,106
| -77% | -$4.9M |
|
2100
The GEO Group
GEO
$4.19B
| $1.3M | ﹤0.01% |
197,815
-260,653
| -57% | -$1.73M |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 561 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 561 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.